Join
Live feed
·
INSIDERFilingvia Quantisnow
Ultragenyx Pharmaceutical Inc. logo

SVP, Chief Accounting Officer Huizenga Theodore Alan was granted 9,392 shares, sold $40,711 worth of shares (967 units at $42.10) and covered exercise/tax liability with 141 shares, increasing direct ownership by 20% to 50,124 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track RARE (Ultragenyx Pharmaceutical Inc.) and more on Quantisnow.